Back to Market返回行情

CHEK Check-Cap Ltd.

NASDAQHealthcare
$1.86+1.64%ClosedMarket Cap: $10.9M

As of 2026-05-21 09:30

Why CHEK matters now

Check-Cap Ltd. (CHEK) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.86 with +1.64% on the session and $10.9M in market capitalization.

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

IL

Exchange

NASDAQ

Beta

0.46

Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-rays. This technology is designed to thoroughly examine the internal surface of the colon, aiming to identify precancerous polyps and other structural irregularities. The company's primary offering, the C-Scan system, is composed of three integral parts: the C-Scan Cap, an ingestible X-ray scanning capsule for detecting suspected polyps; the C-Scan Track, a disposable unit that adheres to the patient's back via biocompatible adhesive patches; and the C-Scan View software. This client/server application enables the download of procedural data from the C-Scan Track, performs detailed analysis, and generates comprehensive reports. Check-Cap Ltd. was founded in 2004 and operates from its headquarters in Isfiya, Israel.